DocGo (DCGO) to Release Quarterly Earnings on Thursday
DocGo (DCGO) is scheduled to release its quarterly earnings report on Thursday. This announcement is pertinent for investors and stakeholders, as earnings reports often influence stock performance and provide insight into a company's financial health and future outlook. The article originates from MarketBeat, a platform that tracks stock market alerts and financial news.
DocGo Announces Upcoming Participation at TD Cowen 46th Annual Health Care Conference
DocGo Inc. (Nasdaq: DCGO) announced that CEO Lee Bienstock will participate in 1x1 meetings and deliver a presentation at the TD Cowen 46th Annual Health Care Conference on Monday, March 2nd, at 9:10 AM ET. A webcast of the presentation will be available on DocGo's investor relations website. DocGo is a leading provider of technology-enabled mobile health services, offering a platform that includes mobile health, remote patient monitoring, ambulance services, and a 50-state virtual care network.
DocGo Inc. (NASDAQ:DCGO) Receives Average Rating of "Hold" from Analysts
DocGo Inc. (NASDAQ:DCGO) has received an average "Hold" rating from seven analysts, with an average 1-year price target of $3.21. The company's stock opened at $0.71, has a market cap of approximately $69.5 million, and is trading with negative earnings. Institutional investors currently own about 56.4% of the stock.
DocGo (NASDAQ:DCGO) Shares Down 6.3% - Here's What Happened
DocGo (NASDAQ:DCGO) shares fell 6.3% on Monday, trading at $0.7286 with significantly lower-than-average volume. The company has a market cap of $71.3 million and reported negative earnings, missing analyst EPS estimates while exceeding revenue expectations in its last quarterly report. Analysts maintain a "Hold" consensus rating with a $3.21 average price target, despite mixed individual ratings.
DocGo receives Nasdaq notice for minimum bid price non-compliance By Investing.com
DocGo (NASDAQ:DCGO) has received a notice from Nasdaq for non-compliance with the minimum bid price rule, as its stock traded below $1.00 for a period. The company has 180 calendar days to regain compliance, which may involve achieving a closing bid price of at least $1.00 for ten consecutive business days or potentially undergoing a reverse stock split. This development comes as the company navigates the winding down of a significant contract and plans to expand its virtual care division.
DocGo receives Nasdaq notice for minimum bid price non-compliance
DocGo Inc. (NASDAQ:DCGO) has received a notice from Nasdaq for non-compliance with the minimum bid price rule, as its stock traded below $1.00 per share for an extended period. The company has 180 days, until July 27, 2026, to regain compliance by having its shares close at $1.00 or more for at least ten consecutive business days. DocGo is exploring options, including a reverse stock split, to address the deficiency and avoid potential delisting.
DocGo Receives Nasdaq Notice Over Minimum Bid Price
DocGo (DCGO) has received a notice from Nasdaq for failing to meet the minimum bid price requirement of $1.00 per share. The company has until July 27, 2026, with a potential extension, to regain compliance or face delisting. An analyst rates DCGO as a Hold with a $0.84 price target.
DocGo Disclosed Failure to Satisfy a Continued Listing Rule or Standard
DocGo (DCGO) received a Nasdaq notice on January 26, 2026, indicating non-compliance with Listing Rule 5550(a)(2) because its common stock's closing bid price fell below $1.00. The company has until July 27, 2026, to regain compliance by maintaining a closing bid of at least $1.00 for ten consecutive business days, with the possibility of an extended period or a reverse stock split. Trading of the stock remains unaffected.
DocGo receives Nasdaq notice for minimum bid price non-compliance
DocGo Inc. announced it received a Nasdaq notice for non-compliance with the minimum bid price rule, as its stock fell below $1.00 per share. The company has 180 days to regain compliance, potentially through a reverse stock split. This news follows recent company updates including exceeding third-quarter earnings expectations, expansion plans for its virtual care division, and an extended share repurchase program.
DocGo’s SteadyMD to expand clinical staff by up to 50% amid GLP-1 demand
DocGo's virtual care division, SteadyMD, is set to increase its clinical staff by up to 50% to meet demand for telehealth services supporting GLP-1 weight loss treatments. This expansion occurs while DocGo's stock (NASDAQ: DCGO) trades near its 52-week low. The company is actively recruiting multi-state licensed clinicians, with onboarding expected to begin soon.
DocGo’s SteadyMD to expand clinical staff by up to 50% amid GLP-1 demand
DocGo's virtual care division, SteadyMD, is set to increase its clinical workforce by up to 50% to address the climbing demand for telehealth services supporting GLP-1 weight loss treatments. This expansion comes as DocGo's stock is trading near its 52-week low. The company is actively seeking clinicians with multiple state licenses to ensure nationwide care delivery.
DocGo’s SteadyMD Announces Immediate Expansion of Clinical Workforce to Meet Rising Demand for Branded GLP-1 Weight Loss Care
DocGo's virtual care division, SteadyMD, is expanding its clinical workforce by up to 50% to meet the accelerating demand for GLP-1 weight loss care through telehealth services. This initiative aims to support existing partnerships with top consumer, healthcare, and digital wellness brands, ensuring high-quality, compliant, and scalable virtual care as the market for GLP-1 treatments grows. SteadyMD is prioritizing the hiring of experienced, multi-state licensed clinicians to enhance nationwide care delivery.
DocGo’s SteadyMD to expand clinical staff by up to 50% amid GLP-1 demand
DocGo's virtual care division, SteadyMD, plans to expand its clinical workforce by up to 50% to meet the rising demand for telehealth services supporting GLP-1 weight loss treatments. This expansion comes as the company's stock is trading near a 52-week low. SteadyMD is prioritizing hiring experienced clinicians with multiple state licenses to support nationwide care delivery.
DocGo Inc. (NASDAQ:DCGO) Receives Consensus Recommendation of "Hold" from Analysts
DocGo Inc. (NASDAQ:DCGO) has received a consensus "Hold" rating from analysts, with an average one-year price target of $3.21. The company recently reported a quarterly EPS miss of ($0.11) against an estimate of ($0.09) and revenue of $70.81 million, slightly exceeding expectations. DocGo's shares opened at a 12-month low of $0.83, showing negative return on equity and net margins.
DocGo Announces Upcoming Participation at 28th Annual Needham Growth Conference
DocGo Inc. announced that CFO Norm Rosenberg will speak at the 28th Annual Needham Growth Conference on January 14th at 1:30 PM Eastern Time. DocGo is a leading provider of technology-enabled mobile health and medical transportation services, aiming to reshape traditional healthcare by delivering high-quality, accessible care to patients. A webcast of the fireside chat will be available on DocGo's investor relations website.
Why DocGo’s CFO is taking the stage at the Needham Growth Conference
DocGo Inc. announced that its Chief Financial Officer, Norm Rosenberg, will participate in a fireside chat and one-on-one meetings at the 28th Annual Needham Growth Conference on January 14th. The company, a leading provider of technology-enabled mobil health and medical transportation services, will make a webcast of the fireside chat available on its investor relations website. This participation highlights DocGo's engagement with the investment community as it continues to advance its proactive healthcare platform.
DocGo Announces Upcoming Participation at 28th Annual Needham Growth Conference
DocGo Inc. announced that its Chief Financial Officer, Norm Rosenberg, will participate in a fireside chat at the 28th Annual Needham Growth Conference on January 14th. DocGo is a leading provider of technology-enabled mobile health and medical transportation services. A webcast of the fireside chat will be available on the investor relations section of their website.
All You Need to Know About Motion Acquisition (DCGO) Rating Upgrade to Buy
This article announces that Zacks Investment Research has upgraded Motion Acquisition (DCGO) from a "hold" to a "buy" rating, setting a $1.25 price target. The upgrade is based on factors such as strong earnings estimate revisions driven by recent quarterly results and positive expectations for future profitability.
DocGo Inc. (NASDAQ:DCGO) Given Consensus Rating of "Hold" by Brokerages
DocGo Inc. (NASDAQ:DCGO) has received a consensus "Hold" rating from seven brokerages, with an average 12-month price target of $3.21. The company's shares are currently trading around $0.91, and it reported a recent quarterly EPS of ($0.11) which missed estimates, though revenue of $70.8 million slightly beat expectations. Institutional investors have recently adjusted their positions in DocGo, with entities like Millennium Management LLC significantly increasing their holdings.
DocGo Inc. (NASDAQ:DCGO) Receives Average Recommendation of "Hold" from Brokerages
DocGo Inc. (NASDAQ:DCGO) has received a consensus "Hold" recommendation from brokerages, with an average 12-month target price of $3.21. The company reported a quarterly EPS of ($0.11), missing estimates, and posted $70.81M in revenue, but remains unprofitable with a negative net margin and a P/E of -1.75. DocGo's shares opened at $0.91, with a market capitalization of approximately $88.9M, indicating low valuation and significant stock volatility.
Halper Sadeh LLC Encourages DocGo Inc. Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of DocGo Inc. (NASDAQ: DCGO) breached their fiduciary duties to long-term shareholders. The firm encourages current DocGo shareholders to contact them to discuss potential legal rights and options, including seeking corporate governance reforms or the return of funds to the company. The investigation aims to enhance shareholder value through improved company policies and oversight.
Claim your share of the $12.5M DocGo securities class action settlement
Investors who purchased DocGo Inc. common stock between November 5, 2021, and September 15, 2023, may be eligible to claim a portion of a $12.5 million securities class action settlement. The lawsuit alleged DocGo and its CEO made false and misleading statements, particularly regarding the CEO's educational background and the company's Medicaid enrollment practices for asylum seekers. The deadline to file a claim is March 9, 2026, with an estimated payout of $0.12 per share before deductions.
Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the DocGo Securities Litigation
Robbins Geller Rudman & Dowd LLP announced a proposed settlement in the DocGo Securities Litigation, a class action lawsuit, for $12.5 million in cash. The settlement resolves all claims for individuals who purchased DocGo Inc. common stock between November 5, 2021, and September 15, 2023. A hearing to approve the settlement will be held on March 24, 2026, and class members must submit a Proof of Claim by March 9, 2026, to share in the distribution.
DocGo stock repurchase program extended by board to June 2026
DocGo's Board of Directors has approved an extension to its share repurchase program, pushing the expiry date from December 31, 2025, to June 30, 2026. The company, trading near its 52-week low, has $26 million remaining in the program, potentially allowing it to repurchase approximately 8% of its outstanding shares. This extension comes amidst a significant decline in Q3 2025 revenue and an EPS miss, though analysts like Stifel and Cantor Fitzgerald maintain positive ratings.
DocGo extends share repurchase program expiration to June 2026
DocGo Inc. (NASDAQ:DCGO) has extended its share repurchase program's expiration date from December 31, 2025, to June 30, 2026, with no other changes to its terms. This program allows DocGo to buy back up to $26 million in common stock, which represents a significant portion of its $90.3 million market cap. The extension suggests management views the stock as undervalued, despite a recent Q3 2025 EPS and revenue miss.
DocGo extends share repurchase program expiration to June 2026
DocGo Inc. has extended its share repurchase program's expiration date from December 31, 2025, to June 30, 2026, with no other changes to its terms. The program allows the company to buy back up to $26 million in common stock, representing a significant portion of its $90.3 million market cap. This comes amidst recent financial challenges, including a Q3 2025 EPS and revenue miss, while analysts from Stifel, Canaccord Genuity, and Cantor Fitzgerald have reiterated ratings with varying price targets.
DocGo Extends Share Repurchase Program to 2026
DocGo (DCGO) has extended its share repurchase program until June 30, 2026, allowing the company to buy back up to $26 million in common stock. This move aims to provide flexibility in managing its capital structure and support stock price stability, signaling confidence in its financial health. TipRanks’ AI Analyst, Spark, rates DCGO as Neutral due to financial performance challenges and bearish technical trends.
HALPER SADEH LLC ENCOURAGES DOCGO INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of DocGo Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders. The firm encourages long-term DocGo shareholders to contact them to discuss potential legal actions, including seeking corporate governance reforms, the return of funds to the company, or other relief. They operate on a contingent fee basis, meaning shareholders would not be responsible for out-of-pocket legal fees.
HALPER SADEH LLC ENCOURAGES DOCGO INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of DocGo Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders to contact them to discuss potential corporate governance reforms, recovery of funds, or other benefits. Shareholder involvement is highlighted as crucial for improving company practices and enhancing shareholder value.
HALPER SADEH LLC ENCOURAGES DOCGO INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of DocGo Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders. The firm encourages long-term DocGo shareholders to contact them to learn about potential legal rights and options, including corporate governance reforms or financial incentives. Halper Sadeh LLC handles these actions on a contingent fee basis.
DocGo Acquires Virtual Care Platform SteadyMD | Findhelp Acquires Uno Health | Vatica Health has Merged with Cozeva
DocGo has acquired virtual care platform SteadyMD to expand its telehealth services across all 50 states, expecting SteadyMD to generate $25 million in revenue in 2025. Findhelp acquired Uno Health to create a full-stack platform for benefit enrollment and social care coordination. Vatica Health merged with Cozeva, combining their #1-rated risk adjustment and quality platforms to enhance value-based care enablement.
DocGo Inc. (NASDAQ:DCGO) Receives Average Recommendation of "Hold" from Brokerages
DocGo Inc. (NASDAQ:DCGO) has received a consensus "Hold" rating from seven brokerage firms, with an average 12-month target price of $3.2125. The company's shares are trading around $1.03, significantly below its 52-week high, and it continues to be unprofitable, missing recent EPS estimates. Despite the "Hold" recommendation, institutional investors have recently increased their stakes, with notable buys from Jefferies, P.A.W. Capital, and Millennium, bringing institutional ownership to about 56.44%.
DocGo Announces Participation at Upcoming December Investor Conferences
DocGo Inc. (Nasdaq: DCGO) has announced that its CEO, Lee Bienstock, will be participating in several investor conferences in December. These include the Noble Capital Markets Emerging Growth Conference, Citi’s 2025 Global Healthcare Conference, and the iAccess Alpha Best Ideas Conference, where he will engage in 1x1 meetings and deliver presentations. Webcasts of the Noble Capital Markets and iAccess Alpha presentations will be available on DocGo’s investor relations website.
DocGo Announces Participation at Upcoming Investor Conferences
DocGo Inc. announced that its management will be attending several investor conferences in November. CFO Norm Rosenberg will participate in the 17th Annual Southwest Ideas Conference and both CEO Lee Bienstock and Rosenberg will be at the Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum and Needham Sixth Annual Tech Week. CEO Lee Bienstock will also engage in the BTIG Digital Health Forum.
DocGo Acquires Virtual Care Platform SteadyMD, Expands Telehealth Services Across All 50 States
DocGo Inc. has acquired virtual care platform SteadyMD, expanding its telehealth services across all 50 states. This strategic acquisition combines DocGo's mobile healthcare delivery capabilities with SteadyMD's virtual care platform, which is projected to generate approximately $25 million in revenue in 2025 and be EBITDA positive by 2026. The acquisition aims to enhance accessibility to high-quality healthcare by integrating virtual and mobile care services.
DOCGO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO
Kahn Swick & Foti, LLC (KSF) is continuing its investigation into DocGo Inc. (NasdaqCM: DCGO) concerning potential breaches of fiduciary duties by its officers and directors. This follows news reports in September 2023 alleging misrepresentations regarding a $4 billion contract with U.S. Customs and Border Protection, which was reportedly worth less, and issues with the CEO's educational background, leading to a securities class action lawsuit. A court recently denied DocGo's motion to dismiss parts of the lawsuit, allowing the case to proceed.
DocGo (NASDAQ: DCGO) to report third-quarter results Nov. 10; call at 5:00 p.m. ET
DocGo Inc. (NASDAQ: DCGO) announced it would release its financial results for the third quarter ended September 30, 2025, after the market closes on Monday, November 10, 2025. The company will also host a conference call on the same day at 5:00 p.m. ET to discuss these results.
DocGo: Revenue Collapse Overshadows Acquisition, Is Cheap But Still A Hold (NASDAQ:DCGO)
DocGo's revenue significantly declined in 2025 due to the loss of a major New York contract, highlighting customer concentration risks. While the acquisition of SteadyMD introduces telehealth capabilities, it faces strong competition, and operating losses have widened. Despite a distressed valuation and negative full-year EBITDA guidance, insider buying and extremely low valuation metrics support a "Hold" rather than a "Sell" stance.
DocGo Acquires SteadyMD for $25 Mn to Expand Telehealth Services
DocGo has acquired telehealth provider SteadyMD for $25 million to expand its telehealth services. This deal integrates SteadyMD's nationwide virtual provider network with DocGo's existing mobile health clinicians, medical transportation, and in-home care offerings. The acquisition aims to enhance comprehensive last-mile care and provide patients with healthcare at any location.
DocGo Acquires SteadyMD to Expand Telehealth Services Nationwide
DocGo Inc. has acquired SteadyMD, a virtual care platform, to expand its telehealth services nationwide. This strategic move combines DocGo’s mobile health infrastructure with SteadyMD’s virtual clinician network, aiming to provide more comprehensive "last-mile" healthcare. SteadyMD’s cofounders will join DocGo’s leadership, and the acquisition is expected to enable broader access to patient-centered virtual care.
DocGo acquires SteadyMD for up to $25M
DocGo has acquired telehealth provider SteadyMD for up to $25 million. This strategic move aims to enhance DocGo's healthcare services, specifically within its Health Tech division. The acquisition was announced on October 21, 2025.
DocGo Acquires Virtual Care Platform Steadymd, Expands Telehealth Services Across All 50 States
DocGo (DCGO) has acquired Steadymd, a virtual care platform, which is expected to generate $25 million in revenue in 2025. This acquisition will expand DocGo's telehealth services across all 50 states and will be funded with existing cash. Steadymd's co-founders will join DocGo's leadership team.
10,000 Members: DocGo Launches Care Gap Closure in New Mexico, Plans Primary Care Services - Stock Titan
DocGo Inc. (Nasdaq: DCGO) is launching a care gap closure program in New Mexico to enhance healthcare access for 10,000 Turquoise Care enrollees, expanding its partnership with a national insurance provider. This initiative will facilitate at-home care, including well-child visits, vaccinations, and chronic disease assessments, with plans to introduce primary care services to reengage patients with their health. The program aims to overcome historical barriers to healthcare access by leveraging mobile clinicians and technology to provide care directly to patients.
DocGo Signs Deal to Launch Care Gap Closure Program in New Mexico With National Insurance Provider - The Joplin Globe
DocGo Inc. has signed a deal to launch a care gap closure program in New Mexico with a national insurance provider, aiming to enhance healthcare access for 10,000 Turquoise Care enrollees. The program leverages DocGo's mobile health services to provide at-home care, including well-child visits, vaccinations, and assessments for hypertension and diabetes control, and plans to introduce primary care services. This initiative, highlighted by DocGo's CEO and Clinical Practice Group CEO, seeks to remove barriers to care and improve health outcomes by meeting patients where they are.
Benign Growth For DocGo Inc. (NASDAQ:DCGO) Underpins Its Share Price
DocGo Inc. currently trades at a low price-to-sales (P/S) ratio of 0.3x, significantly below the industry average of 1.4x, due to recent revenue declines and a negative future outlook. Analysts project a 27% decrease in revenue for DocGo next year, contrasting with an expected 8.7% growth for the broader Healthcare industry. This weak performance and uncertain growth trajectory are seen as the primary reasons for its depressed P/S ratio, making a significant stock price increase unlikely without a material change in its financial trajectory.
Mobile Health Leader DocGo Announces Executive Presentations at Three Major Healthcare Conferences
DocGo Inc. (Nasdaq: DCGO) announced that its management will participate in three upcoming investor conferences in August and September. CFO Norm Rosenberg will present at the Three Part Advisors Midwest Conference, while CEO Lee Bienstock will hold 1x1 meetings and participate in fireside chats at the Cantor Global Healthcare Conference and the Morgan Stanley 23rd Annual Global Healthcare Conference. Webcasts for these events will be available on DocGo's investor relations website.
DocGo Inc. (NASDAQ: DCGO) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims, $4 Million in Stock Sales
Schubert Jonckheer & Kolbe LLP is investigating potential legal claims against DocGo Inc. (NASDAQ: DCGO) concerning alleged false statements about its former CEO's educational background and the company's business development efforts. A U.S. District Court judge allowed key claims in a securities fraud lawsuit to proceed, alleging DocGo misled investors and that insiders sold approximately $4 million in stock during the period of alleged misrepresentation. The firm is encouraging current shareholders to contact them to learn about their legal options following a 25% drop in DocGo's stock price after the truth emerged.
Former DocGo CEO faces foreclosure on Flatiron condo
Former DocGo CEO Anthony Capone is facing foreclosure on his Flatiron District condo. This setback follows his resignation from DocGo in 2023 after reports emerged that he had embellished his resume, particularly regarding a graduate degree from Clarkson University. Capone defaulted on his $2.8 million mortgage from UBS, missing monthly payments since October 2024.
Exclusive | UES pol pushes crackdown on NYC ‘broken’ emergency contracting system
An Upper East Side councilwoman, Julie Menin, is proposing two bills to reform New York City's emergency contracting system, which she deems "broken." The action comes in response to controversial no-bid contracts, such as the $432 million DocGo deal during the migrant crisis and billions spent during the COVID-19 pandemic under previous administrations, which allegedly led to significant taxpayer waste and malfeasance. The proposed legislation aims to cap the mayor's emergency contracting powers at 30 days, mandate quicker audits, and require public disclosure of subcontractors to enhance transparency and fiscal responsibility.
Some digital health companies brace for headwinds amid market volatility while others eye opportunities: Q1 recap
Digital health companies experienced mixed results in Q1 amid market volatility, tariffs, and policy changes. While some, like Amwell and Talkspace, saw opportunities in efficiency and payer-focused strategies, others, such as DocGo, faced significant headwinds due to government policy impacts. Doximity and Waystar showed strong performance, with Doximity anticipating potential slowdowns but investing in AI, and Waystar highlighting its recession-resistant model and AI advancements.
